必须声明标量变量 "@Script_ID"。 探讨新型冠状病毒肺炎疫情期间检验科实验室生物安全防护的措施-《赣南医学院学报》

[1]刘金花.探讨新型冠状病毒肺炎疫情期间检验科实验室生物安全防护的措施[J].赣南医学院学报,2020,40(02):1.
 LIU Jin-hua.Discussion on the measures of biosafety protection in clinical laboratory during the epidemic period of COVID-19[J].,2020,40(02):1.
点击复制

探讨新型冠状病毒肺炎疫情期间检验科实验室生物安全防护的措施()
分享到:

《赣南医学院学报》[ISSN:1001-5779/CN:36-1154/R]

卷:
40
期数:
2020年02期
页码:
1
栏目:
新型冠状病毒专题
出版日期:
2020-03-18

文章信息/Info

Title:
Discussion on the measures of biosafety protection in clinical laboratory during the epidemic period of COVID-19
作者:
刘金花
 (赣州市第五人民医院,江西 赣州 341000)
Author(s):
LIU Jin-hua
(The Fifth People’s Hospital of Ganzhou, Ganzhou, Jiangxi 341000)
关键词:
新型冠状病毒检验科实验室生物安全防护措施
Keywords:
SARS-CoV-2 Laboratory of laboratory Biosafety Protective measures
分类号:
R184
文献标志码:
A
摘要:
目的:探讨新型冠状病毒肺炎(COVID19)疫情期间如何做好检验科实验室日常生物安全防护措施。方法:根据新型冠状病毒(SARS-CoV-2)的微生物学特性和流行病学特点,从标本的采集、标本的处理、检验中、检验后、突发事件等角度分析实验室存在的风险,制定检测时的防护措施以及检测后样本的处理、实验室消毒和新冠标本溢洒事故的处理方法。结果:赣州市COVID-19患者最大的定点医院市第五人民医院检验科实验室严格按照防护措施做好每日生物安全工作,目前未发生医务人员感染事件。结论:实验室生物安全防护措施对防止医务人员感染有良好的预防和控制效果,可以为COVID-19疫情期间检验科实验室做好生物安全防护提供参考作用。
Abstract:
 Objective: To discuss the routine biological safety protection measures of the clinical laboratory during the epidemic period of COVID-19. Methods:Based on the microbiological and epidemiological characteristics of SARS-CoV-2, analyze the risks in the laboratory from the perspective of specimen collection, specimen processing (including pretest, during test, posttest), and emergencies,obtained the protective measures during the test, the method of processing the tested specimen and the items that may be contaminated by the specimen, and the method of laboratory disinfection. Results: Ganzhou Fifth People’s Hospital, as the designated hospital with the largest number of patients with COVID-19 in Ganzhou City, the Laboratory of Clinical Laboratory of the hospital had done a good job in routine biological safety work in strict accordance with biological safety protection measures, and there had been no medical personnel infection at present. Conclusions: The laboratory biosafety protection measures described in this article have a good prevention and control effect on preventing medical personnel from infection, and can provide a reference for the laboratory safety during the epidemic period of COVID-19.

参考文献/References:

[1] 全国人民代表大会常务委员会.中华人民共和国传染病防治法[EB/OL].[2020-02-16].http://www.npc.gov.cn/npc/c238/202001/099a493d03774811b058f0f0ece38078.shtml.
[2] 国家卫生健康委办公厅.国家卫生健康委办公厅关于印发新型冠状病毒实验室生物安全指南(第2版)的通知(国卫办科教函[2020]70号)[EB/OL]. [2020-02-16].http://www.nhc.gov.cn/qjjys/s7948/202001/0909555408d842a58828611dde2e6a26.shtml.
[3] 国家卫生健康委办公厅,国家中医药管理局办公室.关于印发新型冠状病毒感染的肺炎诊疗方案(试行第5版)的通知(国卫办医涵[2020]103号)[EB/OL][2020-02-16]. http://www.gov.cn/zhengce/zhengceku/2020-02/05/content_5474791.htm.
[4] 国家卫生健康委办公厅.国家卫生健康委办公厅关于印发新型冠状病毒感染的肺炎防控方案(第3版)的通知(国卫办疾控函[2020]80号)[EB/OL].[2020-02-16]. http://www.gov.cn/zhengce/zhengceku/2020-01/29/content_5472893.htm.
[5] 国家卫生健康委办公厅.国家卫生健康委办公厅关于印发新型冠状病毒感染的肺炎防控中常见医用防护用品使用范围指引(试行)的通知(国卫办医函[2020]75号)[EB/OL].[2020-02-16].http://www.nhc.gov.cn/yzygj/s7659/202001/e71c5de925a64eafbe1ce790debab5c6.shtml.
[6] 中华人民共和国国务院. 病原微生物实验室生物安全管理条例(国务院令第424号)[EB/OL].[2020-02-16]. http://www.gov.cn/zhengce/content/2008-03/28/content_6264.htm.
[7] HOLSHUE ML, DEBOLT C, LINDQUIST S, et al. First Case of 2019 Novel Coronavirus in the United States[J]. N Engl J Med, 2020,10.1056/NEJMoa2001191. doi:10.1056/NEJMoa2001191.doi:10.1056/NEJMoa2001191
[8] 中华医学会检验医学分会.2019新型冠状病毒肺炎临床实验室生物安全防护专家共识[J/OL].中华检验医学杂志,2020.[2020-02-16].http://http://rs.yiigle.com/m/yufabiao/1180119.htm from=message&isappinstalled=0.

相似文献/References:

[1]曾江,刘辉,罗一钧,等. 新型冠状病毒肺炎患者治疗后咽拭子与诱导痰标本病毒核酸检测的比较[J].赣南医学院学报,2020,40(02):1.
 ZENG Jiang,LIU Hui,LUO Yi jun,et al.Comparison of pharyngeal swab and induced sputum specimens for viral nucleic acid detection in patients with 2019-nCoV after treatment[J].,2020,40(02):1.
[2]颜长建,杨寿慧,袁小亮. 新型冠状病毒的来源和受体的研究进展[J].赣南医学院学报,2020,40(03):1.
 YAN Chang-jian,YANG Shou-hui,YUAN Xiao-liang. Research progress of origin and receptor of SARS-CoV-2[J].,2020,40(02):1.
[3]曾 江,刘 辉,罗一钧,等.新型冠状病毒肺炎患者治疗后咽拭子与诱导痰标本病毒核酸检测的比较[J].赣南医学院学报,2020,40(02):116.[doi:10.3969/j.issn.1001-5779.2020.02.002]
 ZENG Jiang,LIU Hui,LUO Yi-jun,et al.Comparison of pharyngeal swab and induced sputum specimens for viral nucleic acid detection in patients with 2019-nCoV after treatment[J].,2020,40(02):116.[doi:10.3969/j.issn.1001-5779.2020.02.002]
[4]刘金花.探讨新型冠状病毒肺炎疫情期间检验科实验室生物安全防护的措施[J].赣南医学院学报,2020,40(02):129.[doi:10.3969/j.issn.1001-5779.2020.02.005]
 LIU Jin-hua.Discussion on the measures of biosafety protection in clinical laboratory during the epidemic period of COVID-19[J].,2020,40(02):129.[doi:10.3969/j.issn.1001-5779.2020.02.005]

备注/Memo

备注/Memo:
 作者简介:刘金花,女,本科,学士,主管技师,研究方向:临床微生物学。E-mail:159700080274@139.com
 收稿日期:2020-02-16
更新日期/Last Update: 2020-03-06